$29.080
+0.041 (+0.14%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
MRSN stock price ended at $29.08 on Monday, after rising +0.14%
Mersana Therapeutics Inc (MRSN) last closed at $29.08, gaining +0.14%. These facts feed the 1-day and 1-week MRSN price prediction above.
Analyst Consensus
Mersana Therapeutics Inc (MRSN): 4 buy, 0 hold, 0 sell. Outlook: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Forecast Drivers
Mersana Therapeutics Inc (MRSN) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bullish
Seasonality analysis for MRSN
Historically the probability of a positive August return for MRSN is 0.00%. February offers the highest probability of a positive month at 51.28%, while July is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for MRSN
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Aug 2026 | $0.25 | $0.31 | $0.38 | -98.93% |
| Sep 2026 | $0.29 | $0.34 | $0.34 | -98.84% |
| Oct 2026 | $0.37 | $0.38 | $0.42 | -98.71% |
| Nov 2026 | $0.28 | $0.31 | $0.39 | -98.93% |
| Dec 2026 | $0.37 | $0.44 | $0.50 | -98.49% |
In 2026, Mersana Therapeutics Inc (MRSN) is projected to range from $0.25 to $0.50.
Mersana Therapeutics Inc 2026 monthly forecast
In Aug 2026, Mersana Therapeutics Inc is projected to average $0.31, with a low of $0.25 and high of $0.38.
In Sep 2026, Mersana Therapeutics Inc is projected to average $0.34, with a low of $0.29 and high of $0.34.
In Oct 2026, Mersana Therapeutics Inc is projected to average $0.38, with a low of $0.37 and high of $0.42.
In Nov 2026, Mersana Therapeutics Inc is projected to average $0.31, with a low of $0.28 and high of $0.39.
In Dec 2026, Mersana Therapeutics Inc is projected to average $0.44, with a low of $0.37 and high of $0.50.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.